Reader response: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial
2020; Lippincott Williams & Wilkins; Volume: 94; Issue: 14 Linguagem: Inglês
10.1212/wnl.0000000000009229
ISSN1526-632X
AutoresMiguel Leal Rato, Joaquim J. Ferreira,
Tópico(s)Parkinson's Disease Mechanisms and Treatments
ResumoMcGarry et al.1 analyzed the safety data from the 2CARE study. We know there may be a higher risk of suicide in neurodegenerative diseases.2,3 Thus, we agree with an attentive analysis of suicide risk data in Huntington disease (HD) randomized clinical trials (RCTs).4,5 Nevertheless, some aspects of the interpretation, and consequences arising thereof, need attention.
Referência(s)